Third-Dose BNT162b2 Vaccination Elicits Markedly High-Level SARS-CoV-2–Neutralizing Antibodies in Vaccinees Who Responded Poorly to a Second Dose in Japan

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 226; no. 11; pp. 2038 - 2039
Main Authors Amano, Masayuki, Maeda, Kenji, Tsuchiya, Kiyoto, Shimada, Shinya, Mitsuya, Hiroaki
Format Journal Article
LanguageEnglish
Published United States Oxford University Press 28.11.2022
Subjects
Online AccessGet full text

Cover

Loading…
Author Maeda, Kenji
Tsuchiya, Kiyoto
Amano, Masayuki
Mitsuya, Hiroaki
Shimada, Shinya
Author_xml – sequence: 1
  givenname: Masayuki
  orcidid: 0000-0003-0516-9502
  surname: Amano
  fullname: Amano, Masayuki
– sequence: 2
  givenname: Kenji
  surname: Maeda
  fullname: Maeda, Kenji
– sequence: 3
  givenname: Kiyoto
  surname: Tsuchiya
  fullname: Tsuchiya, Kiyoto
– sequence: 4
  givenname: Shinya
  surname: Shimada
  fullname: Shimada, Shinya
– sequence: 5
  givenname: Hiroaki
  surname: Mitsuya
  fullname: Mitsuya, Hiroaki
  email: hmitsuya@hosp.ncgm.go.jp
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35580786$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1u1DAUhS1URKeFLUtkiQ0s0vonduLldGgpaCioM5Rl5MQ3HQ8ZO9hJpbLiHdjydDwJpjPdVEKsru7Vd46uzjlAe847QOg5JUeUKH5sXWtsPF5b3TCiHqEJFbzIpKR8D00IYSyjpVL76CDGNSEk57J4gva5ECUpSjlBv5YrG0z2xkfAJxdLKlnN8JVuGuv0YL3Dp51t7BDxBx2-gulu8bm9XmVzuIEOL6aXi2zmrzL2-8fPCxiHoDv73bprPHWDrb2xELF1Oz9Iy5eVx5cQe-8MGPzJ-5AcB481XkCTjvjukSR5r3vtnqLHre4iPNvNQ_T57HQ5O8_mH9--m03nWcMVHzJTF0KD1qVRCvK8FNBSVihWCiEbTagpQChdUqoYFbRVNfCySAgpNa2FkfwQvdr69sF_GyEO1cbGBrpOO_BjrJiUUuQFkyqhLx-gaz8Gl76rOJVFkWLlPFEvdtRYb8BUfbAbHW6r-9wTkG-BJvgYA7RVCvku8JSh7SpKqr_1Vtt6q129SXb0QHbv_E_B663Aj_3_2D92yrgq
CitedBy_id crossref_primary_10_1016_j_jinf_2023_01_038
crossref_primary_10_1016_j_jinf_2024_106179
crossref_primary_10_1080_21645515_2023_2193074
crossref_primary_10_1016_j_jinf_2023_08_012
crossref_primary_10_1093_infdis_jiac393
crossref_primary_10_1038_s41598_023_28591_3
crossref_primary_10_1038_s41598_023_44484_x
Cites_doi 10.1016/j.cell.2021.12.033
10.1038/s41591-021-01676-0
10.1093/infdis/jiab556
10.1016/S1473-3099(22)00135-9
10.1038/s41598-021-01930-y
ContentType Journal Article
Copyright The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 2022
The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Copyright_xml – notice: The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 2022
– notice: The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
DBID TOX
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
K9.
NAPCQ
7X8
DOI 10.1093/infdis/jiac209
DatabaseName Oxford Journals Open Access Collection
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: TOX
  name: Oxford Journals Open Access Collection
  url: https://academic.oup.com/journals/
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1537-6613
EndPage 2039
ExternalDocumentID 35580786
10_1093_infdis_jiac209
10.1093/infdis/jiac209
Genre Letter
Comment
Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't
Correspondence
GeographicLocations Japan
GeographicLocations_xml – name: Japan
GrantInformation_xml – fundername: NCI NIH HHS
GroupedDBID ---
-DZ
-~X
..I
.2P
.55
.GJ
.I3
.XZ
.ZR
08P
0R~
123
1KJ
1TH
29K
2AX
2WC
36B
3O-
4.4
41~
48X
53G
5GY
5RE
5VS
5WD
6.Y
70D
85S
AABZA
AACGO
AACZT
AAHBH
AAHTB
AAJKP
AAJQQ
AAMVS
AANCE
AAOGV
AAPGJ
AAPNW
AAPQZ
AAPXW
AAQQT
AARHZ
AAUAY
AAUQX
AAVAP
AAWDT
AAWTL
AAYOK
ABBHK
ABDFA
ABDPE
ABEJV
ABEUO
ABGNP
ABIXL
ABJNI
ABKDP
ABLJU
ABNHQ
ABNKS
ABOCM
ABPEJ
ABPLY
ABPPZ
ABPTD
ABQLI
ABQNK
ABSAR
ABSMQ
ABTLG
ABVGC
ABWST
ABXSQ
ABXVV
ABZBJ
ACFRR
ACGFO
ACGFS
ACGOD
ACHIC
ACPQN
ACPRK
ACUFI
ACUTJ
ACUTO
ACYHN
ACZBC
ADBBV
ADEYI
ADGZP
ADHKW
ADHZD
ADIPN
ADJQC
ADOCK
ADQBN
ADRIX
ADRTK
ADULT
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKPW
AEKSI
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEUPB
AEWNT
AEXZC
AFFNX
AFFQV
AFFZL
AFHKK
AFIYH
AFOFC
AFQQW
AFSHK
AFXAL
AFXEN
AFYAG
AGINJ
AGKEF
AGKRT
AGMDO
AGQXC
AGSYK
AGUTN
AHMBA
AHMMS
AHXPO
AI.
AIAGR
AIJHB
AJEEA
ALMA_UNASSIGNED_HOLDINGS
ALUQC
APIBT
APJGH
APWMN
AQDSO
AQKUS
AQVQM
ATGXG
AXUDD
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BR6
BTRTY
BVRKM
BZKNY
C45
CDBKE
CS3
CZ4
D-I
DAKXR
DCCCD
DIK
DILTD
DOOOF
DU5
D~K
EBS
ECGQY
EE~
EIHJH
EJD
EMOBN
ENERS
ESX
F5P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HQ3
HTVGU
HW0
HZ~
IH2
IOX
IPSME
J21
J5H
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JSODD
JST
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
LSO
LU7
M49
MBLQV
MHKGH
MJL
ML0
MVM
N4W
N9A
NEJ
NGC
NOMLY
NOYVH
NU-
NVLIB
O0~
O9-
OAUYM
OAWHX
OCZFY
ODMLO
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
O~Y
P0-
P2P
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
QBD
RD5
ROX
ROZ
RUSNO
RW1
RXO
SA0
SJN
TCURE
TEORI
TJX
TMA
TOX
TR2
VH1
VXZ
W2D
W8F
WH7
X7H
X7M
Y6R
YAYTL
YIF
YKOAZ
YXANX
ZE2
ZGI
ZKG
ZXP
~91
AAYXX
ABPQP
ADNBA
AEMQT
AGORE
AHGBF
AJBYB
AJNCP
ALXQX
CITATION
JXSIZ
CGR
CUY
CVF
ECM
EIF
NPM
K9.
NAPCQ
7X8
ID FETCH-LOGICAL-c393t-db75aeaa8d99e4485ef127928556ca01d7e59a81192151f9be387f1208a1b5d63
IEDL.DBID TOX
ISSN 0022-1899
1537-6613
IngestDate Thu Jul 10 19:08:36 EDT 2025
Mon Jun 30 10:36:23 EDT 2025
Wed Feb 19 02:25:55 EST 2025
Tue Jul 01 01:31:33 EDT 2025
Thu Apr 24 22:59:29 EDT 2025
Tue Feb 18 07:36:33 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
https://creativecommons.org/licenses/by-nc-nd/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c393t-db75aeaa8d99e4485ef127928556ca01d7e59a81192151f9be387f1208a1b5d63
Notes SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
content type line 14
ObjectType-Article-1
ObjectType-Correspondence-2
ObjectType-Commentary-3
content type line 23
ORCID 0000-0003-0516-9502
OpenAccessLink https://dx.doi.org/10.1093/infdis/jiac209
PMID 35580786
PQID 3167780733
PQPubID 41591
PageCount 2
ParticipantIDs proquest_miscellaneous_2666547269
proquest_journals_3167780733
pubmed_primary_35580786
crossref_citationtrail_10_1093_infdis_jiac209
crossref_primary_10_1093_infdis_jiac209
oup_primary_10_1093_infdis_jiac209
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-11-28
PublicationDateYYYYMMDD 2022-11-28
PublicationDate_xml – month: 11
  year: 2022
  text: 2022-11-28
  day: 28
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Oxford
PublicationTitle The Journal of infectious diseases
PublicationTitleAlternate J Infect Dis
PublicationYear 2022
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References Vanshylla (2022112816393842400_jiac209-B4) 2022; 22
Garcia-Beltran (2022112816393842400_jiac209-B2) 2022; 185
Saciuk (2022112816393842400_jiac209-B1) 2022; 225
Gruell (2022112816393842400_jiac209-B3) 2022; 28
Cheng (2022112816393842400_jiac209-B5)
Maeda (2022112816393842400_jiac209-B6) 2021; 11
34726239 - J Infect Dis. 2022 Jan 5;225(1):30-33
References_xml – volume: 185
  start-page: 457
  year: 2022
  ident: 2022112816393842400_jiac209-B2
  article-title: mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant
  publication-title: Cell
  doi: 10.1016/j.cell.2021.12.033
– volume: 28
  start-page: 477
  year: 2022
  ident: 2022112816393842400_jiac209-B3
  article-title: mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
  publication-title: Nat Med
  doi: 10.1038/s41591-021-01676-0
– volume: 225
  start-page: 30
  year: 2022
  ident: 2022112816393842400_jiac209-B1
  article-title: Effectiveness of a third dose of BNT162b2 mRNA vaccine
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jiab556
– ident: 2022112816393842400_jiac209-B5
  article-title: Rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariant BA.2 in a single-source community outbreak
  publication-title: Clin Infect Dis
– volume: 22
  start-page: 445
  year: 2022
  ident: 2022112816393842400_jiac209-B4
  article-title: Durability of omicron-neutralising serum activity after mRNA booster immunisation in older adults
  publication-title: Lancet Infect Dis
  doi: 10.1016/S1473-3099(22)00135-9
– volume: 11
  start-page: 22848
  year: 2021
  ident: 2022112816393842400_jiac209-B6
  article-title: Correlates of neutralizing/SARS-CoV-2-S1-binding antibody response with adverse effects and immune kinetics in BNT162b2-vaccinated individuals
  publication-title: Sci Rep
  doi: 10.1038/s41598-021-01930-y
– reference: 34726239 - J Infect Dis. 2022 Jan 5;225(1):30-33
SSID ssj0004367
Score 2.4482267
SourceID proquest
pubmed
crossref
oup
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2038
SubjectTerms Antibodies, Neutralizing
Antibodies, Viral
BNT162 Vaccine
COVID-19 - prevention & control
Humans
Japan
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Vaccination
Title Third-Dose BNT162b2 Vaccination Elicits Markedly High-Level SARS-CoV-2–Neutralizing Antibodies in Vaccinees Who Responded Poorly to a Second Dose in Japan
URI https://www.ncbi.nlm.nih.gov/pubmed/35580786
https://www.proquest.com/docview/3167780733
https://www.proquest.com/docview/2666547269
Volume 226
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3NbtQwELZQpSIuqJS_hVIZhMTJahzHiX1cSqtS6IK627K3yI69atAqrjbZQ3viHbjydDwJM0l2UfkR3BJl7FgeO_M5M_MNIS-5ctYpGzMuZ4Yls0QwTCmBK1VosM_weUCP7skoPTpLjqdy2pNF139w4WuxBzPtynrvc4lsgpiqBxYYWfInH6Y_MyBFmq14wTkcIdb0jL82v2F-bqS0_YYsWwtzuEXu9tCQDjtd3iO3fLVNNrtikVfb5PZJ7wa_T75NLsqFY29C7enr0YSnsY3puSngaTvR9GAOkk1NMRPHu_kVxXAO9h4DhOh4eDpm--Gcxd-_fB35Zfur4xosGB1WTWkDhhXSsur783Dz6SLQ0zaW1nlHP4awgB6bQA0d43Ha0XYg0OQYLG_1gJwdHkz2j1hfZoEVQouGOZtJ441RTmsPpzXpZxxpBZWUaWEi7jIvtVEcmdMkn2nrhcpAJFKGW-lS8ZBsVKHyjwkF9BkZ7zMd-Six2iFbobDGJdLEFoDKgLDV7OdFz0GOpTDmeecLF3mnrbzX1oC8Wstfduwbf5V8Acr8p9DOStd5v1XrHKkAMoW1Kwfk-foxbDL0nJjKh2WdA4rBIs1xCl086tbI-lXITw84K33yPyN4Su7E7RrlLFY7ZKNZLP0zQDWN3QU8__bdbrusfwB1-vc3
linkProvider Oxford University Press
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Third-Dose+BNT162b2+Vaccination+Elicits+Markedly+High-Level+SARS-CoV-2-Neutralizing+Antibodies+in+Vaccinees+Who+Responded+Poorly+to+a+Second+Dose+in+Japan&rft.jtitle=The+Journal+of+infectious+diseases&rft.au=Amano%2C+Masayuki&rft.au=Maeda%2C+Kenji&rft.au=Tsuchiya%2C+Kiyoto&rft.au=Shimada%2C+Shinya&rft.date=2022-11-28&rft.eissn=1537-6613&rft.volume=226&rft.issue=11&rft.spage=2038&rft_id=info:doi/10.1093%2Finfdis%2Fjiac209&rft_id=info%3Apmid%2F35580786&rft.externalDocID=35580786
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1899&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1899&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1899&client=summon